Survival after brain metastases in Asian patients with HER2+breast cancer

被引：4
|
作者：
Yap, Y. S.
Devi, B. C.
Khorprasert, C.
Cornelio, G. H.
Sutandyo, N.
Yeoh, E.
Landis, S.
Kobayashi, M.
Moon, H.
Ro, J.
机构：
[1] Natl Canc Ctr, Singapore, Singapore
[2] Sarawak Gen Hosp, Sarawak, Malaysia
[3] Chulalongkorn Univ, Bangkok 10330, Thailand
[4] San Juan Dios Hosp, Pasay City, Philippines
[5] Darmais Canc Ctr Hosp, Jakarta, Indonesia
[6] GlaxoSmithKline, Singapore, Singapore
[7] GlaxoSmithKline, Stockley Pk, England
[8] GlaxoSmithKline, Res Triangle Pk, NC USA
[9] GlaxoSmithKline Pte Ltd, Seoul, South Korea
[10] Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
543
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effect of type and timing of systemic therapy on risk of radiation necrosis in patients with HER2+breast cancer brain metastases.
    Park, Christine
    Buckley, Evan
    Van Swearingen, Amanda E. D.
    Giles, Will
    Herndon, James Emmett
    Floyd, Scott R.
    Anders, Carey K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Genomics of HER2+breast cancer
    Perou, C.
    CANCER RESEARCH, 2022, 82 (04)
  • [23] Impact of extracranial disease status on survival after initial central nervous system (CNS) involvement and radiation therapy in HER2+breast cancer brain metastases (BCBM).
    Noteware, Laura
    Ramirez, Luis
    Dalal, Nicole
    Herndon, James Emmett
    Floyd, Scott R.
    Van Swearingen, Amanda E. D.
    Anders, Carey K.
    Sammons, Sarah
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Survival of breast cancer patients with brain metastases
    Elhabbash, M.
    Alwindi, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 290 - 290
  • [25] A study of the anatomic distribution of brain metastases in HER2+breast cancer: Implications for hippocampal avoidance PCI.
    Witt, Jacob
    Pluard, Timothy J.
    Ferraro, Daniel John
    Jaboin, Jerry Jeff
    Thomas, Maria Anne
    Zoberi, Imran
    Robinson, Cliff Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [26] Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
    R Bartsch
    A Berghoff
    U Pluschnig
    Z Bago-Horvath
    P Dubsky
    A Rottenfusser
    C DeVries
    M Rudas
    F Fitzal
    K Dieckmann
    R M Mader
    M Gnant
    C C Zielinski
    G G Steger
    British Journal of Cancer, 2012, 106 : 25 - 31
  • [27] Assessing Neurohormonal in HER2+Breast Cancer Patients With CTRCD
    Albulushi, Arif
    Al-Farhan, Hatem
    JACC: CARDIOONCOLOGY, 2024, 6 (04): : 625 - 626
  • [28] TRASTUZUMAB INDUCED CARDIOTOXICITY IN PATIENTS WITH HER2+BREAST CANCER
    Santamaria Elena, Capilla
    Garcia Beatriz, Benitez
    Jose Antonio, Romero Garrido
    Aunon Pilar, Zamora
    Abad Gema, Casado
    del Valle Luis, Gonzalez
    Ambrosio Alicia, Herrero
    ATENCION FARMACEUTICA, 2013, 15 (04): : 261 - 267
  • [29] PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+breast cancer
    Peddi, Parvin F.
    Hurvitz, Sara A.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (01) : 7 - 13
  • [30] Improved survival after radiotherapy for brain metastases in patients with HER2 positive breast tumors.
    Maur, M
    Frassoldati, A
    Piacentini, F
    Ramundo, D
    Sabbatini, R
    Giovannelli, S
    Ficarra, G
    Bertolini, F
    Falchi, AM
    Conte, PF
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S182 - S182
12345